As injectable and oral GLP-1s evolve, pharma companies face tough choices about capacity, delivery platforms, outsourcing, and supply resilience, says CPHI Milan panel.
The Saint-Julien expansion adds mAb development, bioconjugation and manufacturing capacity while connecting with the CDMO’s HPAPI and payload capabilities in Italy.
The Padova facility will add up to 220 cubic meters of active pharmaceutical ingredient manufacturing capacity and expand Flamma’s Italian network to four cGMP sites.
From endotoxin and pyrogen detection to rapid sterility testing, FUJIFILM Biosciences provides solutions for today's biologics. Explore complementary technologies designed to support regulatory compliance and operational efficiency while giving you flexibility to build a testing approach around your requirements.
